Faculty

Institution

Unit

Venue

Ayush P Gandhi

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hospitalist Medicine

NoneAyush P Gandhi is currently serving as a Hospitalist Medicine faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ayush P Gandhi

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

medicine pharmacology oncology pathology cancer research pharmacotherapy receptors diabetes pharmacological research diabetic medicine applied pharmacology immune checkpoint inhibitors drug safety adverse drug reactions cancer patients neuroscience parkinson's disease alzheimer's disease neurodegenerative diseases hematology neuropsychopharmacology molecular neurodegeneration neuroscience of aging diabetes research cancer care jama oncology phytotherapy research future medicinal chemistry natural product communication histopathology surgical pathology pineal research g protein-coupled receptor neuropeptide receptors neuropeptides vaccine trials cancer management psychopharmacology herbal medicine anti-cancer agents chemoprevention strategies herb-drug interactions pathologic lesions lymphoid neoplasia adrenal disease clinical toxicology chronobiology pineal gland endocrine-related cancers neuroendocrine disorders endocrine diseases endocrine pathways glp-1 receptor agonists future directions retrospective analysis diabetic ketoacidosis clinical outcomes onco-hospitalist medicine service immunotherapy-related adverse events real-world faers analysis qt-related adverse events oncology anti-emetic practice nature meets oncology bilateral adrenal masses adrenal insufficiency comparative renal safety

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Case of Diffuse Large B-Cell Lymphoma Mimicking Disseminated Histoplasmosis With Bilateral Adrenal Masses and Adrenal Insufficiency. (2026)

pathologyadrenal diseasesarcomaadrenal insufficiencysurgical pathologyhistopathologyanatomical pathologylymphoid neoplasiapathologic lesionsbilateral adrenal masses

Glp-1 Receptor Agonists at the Crossroads of Circadian Biology, Sleep, and Metabolic Disease. International Journal of Molecular Sciences (2026)

glp-1 receptorpineal glandphysiologysleepcircadian biologychronobiologymetabolic diseasepineal researchpharmacologyendocrinologypharmacological researchreceptors

qt-related adverse eventsdrug safetyoncology anti-emetic practicepsychiatryneuropharmacologyapplied pharmacologyadverse drug reactionsmedicinepharmacologypsychopharmacologyreal-world faers analysispharmacotherapyoncology

Comparative Renal Safety of Tirzepatide and Semaglutide: An FDA Adverse Event Reporting System (Faers)—Disproportionality Study. Journal of Clinical Medicine (2025)

toxicologycomparative renal safetydrug safetyclinical toxicologynephrologyapplied pharmacology—disproportionality studyadverse drug reactionsmedicinepatient safetyclinical researchurologypharmacotherapy

Etiologies and Outcomes of Diabetic Ketoacidosis in Cancer Patients: A Retrospective Analysis. Cancers (2025)

diabetic ketoacidosispathologydiabetesdiabetes researchcancer researchdiabetic medicinemedicinecancer patientsretrospective analysishealth sciencesoncology

Glp-1 Receptor Agonists in Alzheimer’s and Parkinson’s Disease: Endocrine Pathways, Clinical Evidence, and Future Directions. Frontiers in Endocrinology (2025)

neuroscience of agingalzheimer's diseaseglp-1 receptor agonistsmolecular neurodegenerationneuropeptide receptorsneuropsychopharmacologyparkinson's diseaseneuroscienceneurodegenerative diseasesendocrine pathwaysfuture directionspharmacologyg protein-coupled receptorneuropeptidespharmacological researchreceptors

Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers (2025)

radiation oncologyvaccine trialsimmunotherapyhematologyimmune checkpoint inhibitorsjama oncologymedicineimmunotherapy-related adverse eventscancer managementclinical outcomesonco-hospitalist medicine servicecancer careoncology

Sun-589 Diabetic Ketoacidosis in Cancer Patients: Etiological Patterns in a Tertiary Care Center. Journal of the Endocrine Society (2025)

sun-589 diabetic ketoacidosispathologydermatologycancer researchdiabetic medicinetertiary care centermedicinecancer patientsdiabetesdiabetes therapies

The Evolving Management of Endocrine Disorders Induced by Checkpoint Inhibitors: Insights From the Ciited Group. Expert Review of Endocrinology & Metabolism (2025)

oncogenesendocrine-related cancersciited groupmolecular medicinecell biologycheckpoint inhibitorsneuroendocrine disorderspharmacologytherapeutic targetsexperimental medicineendocrine diseasesendocrinologypharmacotherapyimmune checkpoint inhibitorsoncologyendocrine disorders

When Nature Meets Oncology: Unraveling Herb–Drug Interactions in Cancer Therapy. International Journal of Molecular Sciences (2025)

future medicinal chemistryradiation oncologyanti-cancer agentsnatural product communicationnature meets oncologyherbal medicinecancer researchchemoprevention strategiespharmacologytherapeutic targetsdrug discoveryphytotherapy researchherb-drug interactions

1
10 / page

Ayush P Gandhi

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Hospitalist Medicine

NoneAyush P Gandhi is currently serving as a Hospitalist Medicine faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ayush P Gandhi

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Case of Diffuse Large B-Cell Lymphoma Mimicking Disseminated Histoplasmosis With Bilateral Adrenal Masses and Adrenal Insufficiency. (2026)

pathologyadrenal diseasesarcomaadrenal insufficiencysurgical pathologyhistopathologyanatomical pathologylymphoid neoplasiapathologic lesionsbilateral adrenal masses

Glp-1 Receptor Agonists at the Crossroads of Circadian Biology, Sleep, and Metabolic Disease. International Journal of Molecular Sciences (2026)

glp-1 receptorpineal glandphysiologysleepcircadian biologychronobiologymetabolic diseasepineal researchpharmacologyendocrinologypharmacological researchreceptors

Comparative Renal Safety of Tirzepatide and Semaglutide: An FDA Adverse Event Reporting System (Faers)—Disproportionality Study. Journal of Clinical Medicine (2025)

Etiologies and Outcomes of Diabetic Ketoacidosis in Cancer Patients: A Retrospective Analysis. Cancers (2025)

diabetic ketoacidosispathologydiabetesdiabetes researchcancer researchdiabetic medicinemedicinecancer patientsretrospective analysishealth sciencesoncology

Glp-1 Receptor Agonists in Alzheimer’s and Parkinson’s Disease: Endocrine Pathways, Clinical Evidence, and Future Directions. Frontiers in Endocrinology (2025)

Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers (2025)

Sun-589 Diabetic Ketoacidosis in Cancer Patients: Etiological Patterns in a Tertiary Care Center. Journal of the Endocrine Society (2025)

sun-589 diabetic ketoacidosispathologydermatologycancer researchdiabetic medicinetertiary care centermedicinecancer patientsdiabetesdiabetes therapies

The Evolving Management of Endocrine Disorders Induced by Checkpoint Inhibitors: Insights From the Ciited Group. Expert Review of Endocrinology & Metabolism (2025)

When Nature Meets Oncology: Unraveling Herb–Drug Interactions in Cancer Therapy. International Journal of Molecular Sciences (2025)

1
10 / page